Search

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.

… Thursday, May 30, 2019 Summary Research has found that the incidence of several cancers is on the rise among younger adults in the United States. An MSK expert on diet and cancer explains how the obesity epidemic is to blame. There is a lot to celebrate in the battle against cancer. Research by the American

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

… Wednesday, September 19, 2012 Summary Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes. Memorial Sloan Kettering researchers have discovered a way that cancer cells may

… Job Title Lab Manager

A phase 2 randomized clinical trial at MSK has found that acupuncture can improve cognitive abilities in breast cancer survivors experiencing "brain fog."

… Friday, December 12, 2025 Cancer-related cognitive impairment — often called “brain fog” or “chemo brain” — has been shown to affect about 40% of breast cancer survivors, making it difficult for them to focus, work, and perform daily tasks.  But acupuncture may help alleviate this brain fog, according

… Job Title Lead, Drug Development, MSK Therapeutics Bridge Labs Olivia Vergnolle, PhD, is a Lead Drug Development in the MSK Therapeutics Bridge Labs (TxBL) program, in the Office of Entrepreneurship & Commercialization (OEC). Her responsibilities include protein engineering and bioanalytical characterization

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

… Friday, October 1, 2010 Summary As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials. As part of a commitment

I am a board-certified nurse practitioner with special training in palliative and hospice care. Palliative (supportive) care focuses on managing pain, symptoms, and treatment of the person, rather than just the disease, to enhance quality of life. I care for patients with all types of cancer at Memorial Hospital in New York City.

… Job Title Nurse Practitioner I am a board-certified nurse practitioner with special training in palliative and hospice care . Palliative (supportive) care focuses on managing pain , symptoms, and treatment of the person, rather than just the disease, to enhance quality of life. I care for patients with

… Job Title Research Fellow Email [email protected]

… Job Title Assistant to Chair Email [email protected] Office Phone (212) 639-8397

… The Dana Pe'er Lab We are seeking a creative developer with a strong statistics and machine learning background to join Sloan Kettering Institute’s Single Cell Research Initiative (SCRI). The team’s goal is to develop cutting-edge algorithms to interpret the flood of data emerging from single-cell technologies